Rozman de Moraes, A.; Erdogan, E.; Azhar, A.; Reddy, S.K.; Lu, Z.; Geller, J.A.; Graves, D.M.; Kubiak, M.J.; Williams, J.L.; Wu, J.;
et al. Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Curr. Oncol. 2024, 31, 1335-1347.
https://doi.org/10.3390/curroncol31030101
AMA Style
Rozman de Moraes A, Erdogan E, Azhar A, Reddy SK, Lu Z, Geller JA, Graves DM, Kubiak MJ, Williams JL, Wu J,
et al. Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Current Oncology. 2024; 31(3):1335-1347.
https://doi.org/10.3390/curroncol31030101
Chicago/Turabian Style
Rozman de Moraes, Aline, Elif Erdogan, Ahsan Azhar, Suresh K. Reddy, Zhanni Lu, Joshua A. Geller, David Mill Graves, Michal J. Kubiak, Janet L. Williams, Jimin Wu,
and et al. 2024. "Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital" Current Oncology 31, no. 3: 1335-1347.
https://doi.org/10.3390/curroncol31030101
APA Style
Rozman de Moraes, A., Erdogan, E., Azhar, A., Reddy, S. K., Lu, Z., Geller, J. A., Graves, D. M., Kubiak, M. J., Williams, J. L., Wu, J., Bruera, E., & Yennurajalingam, S.
(2024). Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Current Oncology, 31(3), 1335-1347.
https://doi.org/10.3390/curroncol31030101
